Efficacy and safety of RS plus bevacizumab versus RS plus fruquintinib as the third‐line therapy in patients with refractory metastatic colorectal cancer: A real‐world propensity score matching study

Ähnliche Einträge

• Efficacy and safety of various corticosteroids in the treatment of children with allergic rhinitis: A systematic review and network meta‐analysis
  von: Yuxin Li, et al.
  Veröffentlicht: (2024)
• Efficacy and safety of Supine Daoyin in the treatment of acute exacerbation of chronic obstructive pulmonary disease: A randomized controlled trial
  von: Jiansheng Li, et al.
  Veröffentlicht: (2024)
• Impact of hormone replacement therapy on all‐cause and cancer‐specific mortality in colorectal cancer: A systematic review and dose‒response meta‐analysis of observational studies
  von: Kefeng Liu, et al.
  Veröffentlicht: (2024)
• Efficacy of Acceptance and Commitment Therapy for Smoking Cessation: A Systematic Review and Meta‐Analysis
  von: Jia Fan, et al.
  Veröffentlicht: (2025)
• Effectiveness of narrowband ultraviolet B monotherapy versus combination therapy with systemic agents in patients with early‐stage mycosis fungoides and the association with plaque lesions
  von: Yao Qin, et al.
  Veröffentlicht: (2024)